跳至主要内容
临床试验/NCT06152120
NCT06152120已完成不适用

Preparing Surrogates of Dementia Patients for In-the-moment Decision Making Through a Structured Advance Care Planning Intervention: A Mixed-methods Pilot Study

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2023年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
58
试验地点
1
主要终点
Modified Family Member Decision-Making Self-efficacy Scale (FDMSE) - Chinese version

研究概览

简要总结

The goal of this clinical trial is to evaluate the effects of a nurse-facilitated post-discharge advance care planning intervention with family surrogates of dementia patients on outcomes that reflect the preparedness of surrogates in decision-making.

The main question it aims to answer is, whether the ACP intervention as compared with usual care will increase family surrogates' self-efficacy in surrogate decision-making and reduce their levels of distress, and increase patient comfort and reduce acute healthcare utilization at 2 and 6 months.

Participants will be randomized to ACP intervention vs. usual care.

  1. patients of the Intervention group will be assessed on palliative care needs, and surrogates of the Intervention group will participate in 2-3 nurse-led ACP consultations;
  2. surrogates of both intervention and control groups will complete 3 surveys at different time points during their participation of the study.

Researchers will compare the intervention group and control group to see any differences in:

  1. surrogate preparedness for decision-making,
  2. distress of surrogate and satisfaction with the care of loved one with dementia at the end-of-life,
  3. enrolment in Community Geriatric Assessment Team end-of-life care program,
  4. advanced care program documentation in medical record,
  5. patient comfort at end-of-life,
  6. hospitalizations in the last 6 months of life.

详细描述

In order to test the ACP interventions that aim to engage surrogates' participation in ACP and improve their preparedness for decision-making rather than on documentation of advance care plans alone, the research team has developed a pilot structured, nurse-facilitated post-discharge ACP intervention with the aim to improve surrogates' preparedness for in-the-moment decision-making.

It does so by incorporating best practices for ACP communication, drawing from prior work of the research team and existing literature, combined with a focus on developing surrogates' self-efficacy for decision-making guided by Bandura's Social Cognitive Theory.

This application aims to test the intervention's effects on surrogate outcomes (decision-making self-efficacy and distress), patient outcomes (patient comfort and healthcare utilization), as well as process outcomes (ACP documentation, end-of-life care discussions between family members, and enrolment in end-of-life care programs).

The research hypotheses to be tested are as follows: the investigators will test whether the ACP intervention as compared with usual care will increase family surrogates' self-efficacy in surrogate decision-making and reduce their levels of distress, and increase patient comfort and reduce acute healthcare utilization at 2 and 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

Research staff will be blinded to the study arm when collecting data from family surrogates by telephone at follow up time-points. The study biostatistician will also be blinded to the allocation of the study arm.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Modified Family Member Decision-Making Self-efficacy Scale (FDMSE) - Chinese version

时间窗: Baseline, 2-month, 6-month

This is a modified 17-item version of the FDMSE, a valid and reliable scale that quantifies a family member's confidence (0-100, where 100 = greatest self-efficacy) in end-of-life care decision-making for a loved one.

Family Distress in Advanced Dementia Scale (FDAD) Dementia Preparedness Subscale - Chinese version

时间窗: Baseline, 2-month, 6-month

The FDAD is a validated 21-item scale rated on a 1-5 scale, with higher scores indicating greater family distress. The scale assesses three domains of distress of family members of nursing home residents with dementia: Emotional Distress, Dementia Preparedness, and Clinician Relations. The Chinese version of the FDAD has high content validity (CVI = 0.95). It has good internal consistency (Cronbach's alpha 0.83) and moderate test-retest reliability (ICC = 0.64). We will use the 5-item Dementia Preparedness subscale to evaluate family distress associated with lack of knowledge of the course of dementia and surrogate medical decision making.

次要结局

  • End-of-life care discussions with other family members(Baseline, 2-month, 6-month)
  • Enrolment in Community Geriatric Assessment Team End-of-Life (CGAT EOL) care program(2-month, 6-month)
  • Comfort Assessment in Dying with Dementia (CAD-EOLD)(2-month, 6-month)
  • Documentation of ACP discussions with medical providers(Baseline, 2-month, 6-month)
  • Unplanned hospital admissions and hospitalization days(2-month, 6-month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

YUEN Jacqueline Kwan Yuk

Clinical Assistant Professor

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验